Current Opinion in Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 36.0% | 0.979 | Q2 | 83.4% |
| 2024 | 2.4 | Q3 | 39.0% | 1.123 | Q2 | 87.0% |
| 2023 | 2.8 | Q2 | 48.0% | 0.990 | Q2 | 85.3% |
| 2022 | 3.4 | Q3 | 51.2% | 0.971 | Q2 | 85.6% |
| 2021 | 3.9 | Q3 | 53.8% | 1.022 | Q2 | 87.0% |
| 2020 | — | — | 1.297 | Q2 | 90.3% | |
| 2019 | — | — | 1.275 | Q2 | 90.2% | |
| 2018 | — | — | 1.572 | Q1 | 92.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1040-8746
ISSN
1531-703X
country
UScoverage
1989-2026